secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009961
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma reports preliminary cash of ~$450M as of Dec 31, 2025
-------------------------------------------------------------------

- Cash, cash equivalents and short-term investments ~$450M as of Dec 31, 2025 (preliminary, unaudited).
- Company presenting at 44th Annual J.P. Morgan Healthcare Conference on Jan 13, 2026.
- Financial data is subject to change upon completion of audited FY 2025 statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312526009961/0001193125-26-009961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312526009961/vor-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer